
CAS 1129403-56-0
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 prodotti.
Amcasertib
CAS:<p>Amcasertib (BBI503) is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.</p>Formula:C31H33N5O2SPurezza:97.56% - >99.99%Colore e forma:SolidPeso molecolare:539.69Amcasertib (BBI503)
CAS:Amcasertib is a β-catenin inhibitor that inhibits tumor growth and metastasis. It is currently in clinical trials for the treatment of cancer. Amcasertib inhibits the phosphorylation of β-catenin by GSK3β, which leads to its degradation by proteasomes, thereby reducing cellular levels of β-catenin. Amcasertib has also been shown to enhance the cytotoxicity of folfirinox, an anticancer drug. Amcasertib has a hydroxyl group at C-2 and a carbonyl group at C-4, which are necessary for binding to β-catenin. The lack of a disulfide bond makes amcasertib more stable than other potential β-catenin inhibitors.Formula:C31H33N5O2SPurezza:Min. 95%Peso molecolare:539.69 g/mol




